VeriMompalmitoyl dipeptide-5 diaminobutyroyl hydroxythreonine hamilelikte güvenli mi?
Reviewed by VeriMom Editorial Team · Last reviewed
İçerikler
palmitoyl dipeptide-5 diaminobutyroyl hydroxythreonine
BILINEN RISK YOK100
/100
0
Pregnancy-safe products containing palmitoyl dipeptide-5 diaminobutyroyl hydroxythreonine
Matte
Matte Growth Factor Serum
99/100
ISOMERS Skincare
ISOMERS Skincare Stemgenesis® Pur Orchid Concentrate
99/100
TAHNYC
TAHNYC Contour Concentrated 10 Peptide Serum
99/100
Basiclab
Basiclab Esteticus Antioxidant Compensating Serum With 20% Vitamin C
98/100
The Neo Mortal
The Neo Mortal Hand And Body Balm V6
98/100
Nécessaire
Nécessaire Hand Cream *2023 Update*
98/100
RevivSerums
RevivSerums Telomerase 6-In-1 Multi-Corrective Serum
98/100
Basiclab
Basiclab Esteticus Skin Structure Regenerating Serum with 1% Ceramides and 5% Peptides
98/100
Bigger Than Beauty
Bigger Than Beauty Light Weight Moisturizer
98/100
HighDroxy
HighDroxy Re:store Ageless
98/100
Related ingredients
Ayrıca bakın
Sources & references
Authoritative references used to score this ingredient.
Frequently asked questions
- palmitoyl dipeptide-5 diaminobutyroyl hydroxythreonine hamilelikte güvenli mi?
- No harmonised CLP classification or SCCS/CIR reproductive safety restriction was found for this ingredient. No peer‑reviewed reproductive or developmental toxicity data were identified. As a large palmitoyl‑peptide used topically, dermal absorption is expected to be negligible, and there is no structural or mechanistic evidence of reproductive toxicity. Sources consulted include PubChem, CosIng, PubMed (no reproductive studies), ECHA (no Annex VI harmonised classification), and EWG.
- palmitoyl dipeptide-5 diaminobutyroyl hydroxythreonine emzirirken güvenli mi?
- No data indicating transfer into breast milk or lactation-related toxicity. Given the peptide's size/polarity and expected negligible systemic absorption after topical use, risk of exposure to breastfed infants is unlikely. No regulatory flags (ECHA Annex VI, SCCS, CIR) or peer‑reviewed evidence were found.
- palmitoyl dipeptide-5 diaminobutyroyl hydroxythreonine bebek cildi için güvenli mi?
- No infant‑specific reproductive or toxicology data located. Adult dermal absorption is expected negligible; however, infant skin has a higher surface‑area‑to‑weight ratio and immature barrier, so exposure score is increased by +1 for 0–3 yr. There is still no mechanistic or hazard evidence suggesting reproductive or developmental toxicity for infants.
- VeriMom palmitoyl dipeptide-5 diaminobutyroyl hydroxythreonine nasıl puanlıyor?
- VeriMom palmitoyl dipeptide-5 diaminobutyroyl hydroxythreonine'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 100/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte palmitoyl dipeptide-5 diaminobutyroyl hydroxythreonine yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.